Literature DB >> 14693534

Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium.

Mahomed-Yunus S Moosa1, Jack D Sobel, Hussain Elhalis, Wenjin Du, Robert A Akins.   

Abstract

Fluconazole (FLZ) has emerged as a highly successful agent in the management of systemic infections of Candida. Cure rates for symptomatic candidiasis following single 150-mg FLZ dose therapy exceed 90%. In vitro, however, FLZ is fungistatic only in a narrow pH range and is not effective at vaginal pH, 4.2. This study evaluated the effect of FLZ on Candida albicans under in vitro conditions resembling the vaginal microenvironment, using vagina-simulative medium (VS). We found that FLZ was fungicidal for C. albicans in VS, but not in other media at the same pH, 4.2. In VS, FLZ was fungicidal at concentrations of >/=8 micro g/ml and reduced viability by greater than 99.9%. Analysis of the components of VS indicated that 17 mM acetic acid, a concentration achieved in the vagina, was responsible for the synergistic, fungicidal effect. This effect was not seen at neutral pH. Other substrates were not effective substitutes for acetic acid; however, short-chained carboxylic acids, glyoxylate and malonate, were effective. Most strains of C. albicans that were resistant to FLZ under standard conditions were killed by FLZ plus acetate. Other species of Candida were also killed, except C. krusei and C. glabrata. This study shows that FLZ has fungicidal activity for Candida species under in vitro conditions that mimic the vaginal microenvironment. This raises the possibility that FLZ may also have fungicidal effects during treatment of vaginal candidiasis. Elucidating the mechanism by which FLZ and acetate interact may disclose vulnerable pathways that could be exploited in drug development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693534      PMCID: PMC310176          DOI: 10.1128/AAC.48.1.161-167.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  52 in total

1.  Effects of ethanol and other alkanols on transport of acetic acid in Saccharomyces cerevisiae.

Authors:  M Casal; H Cardoso; C Leão
Journal:  Appl Environ Microbiol       Date:  1998-02       Impact factor: 4.792

2.  Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.

Authors:  S Arikan; M Akova; M Hayran; O Ozdemir; M Erman; D Gür; S Unal
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

3.  Epidemiology of nosocomial fungal infections.

Authors:  S K Fridkin; W R Jarvis
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.

Authors:  P F Troke; R J Andrews; K W Brammer; M S Marriott; K Richardson
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

5.  Interaction of Candida albicans, macrophages and fluconazole: in vitro and ex vivo observations.

Authors:  V Tullio; A M Cuffini; C De Leo; F Perrone; N A Carlone
Journal:  J Chemother       Date:  1996-12       Impact factor: 1.714

6.  In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.

Authors:  K A McIntyre; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

7.  Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.

Authors:  N Troillet; C Durussel; J Bille; M P Glauser; J P Chave
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

8.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

9.  Cytochrome c release and mitochondria involvement in programmed cell death induced by acetic acid in Saccharomyces cerevisiae.

Authors:  Paula Ludovico; Fernando Rodrigues; Agostinho Almeida; Manuel T Silva; Antoni Barrientos; Manuela Côrte-Real
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

10.  Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol.

Authors:  S L Kelly; D C Lamb; A J Corran; B C Baldwin; D E Kelly
Journal:  Biochem Biophys Res Commun       Date:  1995-02-27       Impact factor: 3.575

View more
  23 in total

1.  Management of recurrent vulvovaginal candidiasis: unresolved issues.

Authors:  Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.725

2.  A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives.

Authors:  Anke Burger-Kentischer; Doris Finkelmeier; Petra Keller; Jörg Bauer; Holger Eickhoff; Gerald Kleymann; Walid Abu Rayyan; Anurag Singh; Klaus Schröppel; Karin Lemuth; Karl-Heinz Wiesmüller; Steffen Rupp
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

3.  Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.

Authors:  Chiatogu Onyewu; Natalie A Afshari; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2006-08-21       Impact factor: 5.191

4.  Genomic expression program involving the Haa1p-regulon in Saccharomyces cerevisiae response to acetic acid.

Authors:  Nuno P Mira; Jorg D Becker; Isabel Sá-Correia
Journal:  OMICS       Date:  2010-10

Review 5.  Adaptive response and tolerance to weak acids in Saccharomyces cerevisiae: a genome-wide view.

Authors:  Nuno P Mira; Miguel Cacho Teixeira; Isabel Sá-Correia
Journal:  OMICS       Date:  2010-10

6.  Penetration of Candida biofilms by antifungal agents.

Authors:  Mohammed A Al-Fattani; L Julia Douglas
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  Glucose directly promotes antifungal resistance in the fungal pathogen, Candida spp.

Authors:  Santi M Mandal; Denial Mahata; Ludovico Migliolo; Aditya Parekh; Partha S Addy; Mahitosh Mandal; Amit Basak
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

8.  Exogenous Reproductive Hormones nor Candida albicans Colonization Alter the Near Neutral Mouse Vaginal pH.

Authors:  Jian Miao; Hubertine M E Willems; Brian M Peters
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

Review 9.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

10.  Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills Candida albicans.

Authors:  Jakub Suchodolski; Jakub Muraszko; Przemysław Bernat; Anna Krasowska
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.